Is GMRE's Q4 2024 EPS recovery a positive sign?

**Global Medical REIT Inc.'s (GMRE) Q4 2024 EPS recovery is not currently available**, and thus cannot be assessed as a positive sign at this time. However, we can analyze the company's performance and market trends to gauge its overall health and potential future outlook.

1. **Occupancy Rate and Lease Term**: GMRE's occupancy rate stands at 96.1% with a weighted average lease term of 5.6 years. A high occupancy rate indicates a strong demand for its properties, which is a positive sign.
2. **Net Income and Revenue**: The company reported a net income of $1.8 million or 3 per share in Q3 2024, which is a decrease from $3.1 million or 5 per share in the same period of the previous year. Additionally, revenue decreased by approximately 3.7% compared to the prior year quarter. These figures suggest that GMRE is facing challenges, which could impact its EPS recovery.
3. **Total Expenses**: GMRE's total expenses were $32.7 million, down from $33 million in Q3 2023. This reduction in expenses could potentially lead to improved profitability and possibly an EPS recovery if revenue trends improve.
4. **Acquisitions and Dividends**: GMRE has announced acquisitions and joint ventures, including the acquisition of $80.3 million in single tenant triple-net medical real estate in 2024. The company has also announced first quarter 2025 common and preferred dividends, which could be a positive sign for investors.
5. **Analyst Expectations**: Analysts expect GMRE to post earnings of $0.21 per share for the quarter, which is a baseline for evaluating the company's performance. If the EPS recovery trend continues or improves, it could be a positive sign.

In conclusion, while the Q4 2024 EPS recovery is not currently available, GMRE's high occupancy rate, strategic acquisitions, and dividend announcements suggest a positive outlook. However, the decrease in net income and revenue indicates that the company faces challenges. The absence of specific EPS data for Q4 2024 prevents a definitive assessment, but the overall direction of the company's initiatives points towards potential recovery and growth.